These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7927199)

  • 1. Transferrin soluble receptor: a possible probe for detection of erythropoietin abuse by athletes.
    Gareau R; Gagnon MG; Thellend C; Chénard C; Audran M; Chanal JL; Ayotte C; Brisson GR
    Horm Metab Res; 1994 Jun; 26(6):311-2. PubMed ID: 7927199
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
    Robinson N; Saugy M; Mangin P
    Clin Lab; 2003; 49(1-2):57-62. PubMed ID: 12593476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of blood erythroid markers useful in revealing erythropoietin abuse in athletes.
    Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Gargiullo E; Parisi A; Pigozzi F
    Blood Cells Mol Dis; 2001; 27(3):559-71. PubMed ID: 11355895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preanalytical phase of soluble receptor of transferrin.
    Banfi G
    Int J Sports Med; 2007 Jan; 28(1):88-9. PubMed ID: 17203438
    [No Abstract]   [Full Text] [Related]  

  • 5. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
    Lippi G; Franchini M; Guidi G
    Haematologica; 2004 Apr; 89(4):ELT05. PubMed ID: 15075118
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
    Parisotto R; Gore CJ; Emslie KR; Ashenden MJ; Brugnara C; Howe C; Martin DT; Trout GJ; Hahn AG
    Haematologica; 2000 Jun; 85(6):564-72. PubMed ID: 10870111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring erythropoietin abuse in athletes.
    Magnani M; Corsi D; Bianchi M; Paiardini M; Galluzzi L; Parisi A; Pigozzi F
    Br J Haematol; 1999 Jul; 106(1):260-1. PubMed ID: 10444203
    [No Abstract]   [Full Text] [Related]  

  • 9. A third generation approach to detect erythropoietin abuse in athletes.
    Sharpe K; Ashenden MJ; Schumacher YO
    Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin abuse in athletes.
    Gareau R; Audran M; Baynes RD; Flowers CH; Duvallet A; Senécal L; Brisson GR
    Nature; 1996 Mar; 380(6570):113. PubMed ID: 8600382
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood test may help discourage doping.
    Expert Rev Mol Diagn; 2002 Mar; 2(2):95. PubMed ID: 11962345
    [No Abstract]   [Full Text] [Related]  

  • 12. Second-generation blood tests to detect erythropoietin abuse by athletes.
    Gore CJ; Parisotto R; Ashenden MJ; Stray-Gundersen J; Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Hahn AG
    Haematologica; 2003 Mar; 88(3):333-44. PubMed ID: 12651273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Genetic Doping" with erythropoietin cDNA in primate muscle is detectable.
    Lasne F; Martin L; de Ceaurriz J; Larcher T; Moullier P; Chenuaud P
    Mol Ther; 2004 Sep; 10(3):409-10. PubMed ID: 15336641
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rogue athletes and recombinant DNA technology: challenges for doping control.
    Azzazy HM; Mansour MM
    Analyst; 2007 Oct; 132(10):951-7. PubMed ID: 17893796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to confirm C.E.R.A. doping in athletes' blood?
    Leuenberger N; Lamon S; Robinson N; Giraud S; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):101-3. PubMed ID: 21889277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory screening for erythropoietin abuse in sport: an emerging challenge.
    Lippi G; Guidi G
    Clin Chem Lab Med; 2000 Jan; 38(1):13-9. PubMed ID: 10774956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengths and weaknesses of established indirect models to detect recombinant human erythropoietin abuse on blood samples collected 48-hr post administration.
    Connes P; Caillaud C; Simar D; Villard S; Sicart MT; Audran M
    Haematologica; 2004 Jul; 89(7):891-2. PubMed ID: 15257956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peculiar pattern of expression of the transferrin receptor (CD71) by reticulocytes in patients given recombinant human erythropoietin (rHuEPO): a novel marker for abuse in sport?
    Borrione P; Parisi A; Salvo RA; Spaccamiglio A; Pautasso M; Baraban D; Piccoli GB; Pigozzi F; Angeli A
    J Biol Regul Homeost Agents; 2007; 21(3-4):79-88. PubMed ID: 18261259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.